During the pandemic, EMA sped up approval for vaccines/therapeutics, & saved lives. Glad to hear about its activity on streamlining process to accelerate assessments for high-priority products.
We need to learn and apply the lessons in non-emergency times!

@EPPGroup
#COVID19

🐦🔗: https://n.respublicae.eu/Kympouropoulos/status/1640383488426668036